Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Ameliorate Intervertebral Disc Degeneration By Regulating Hmgb1 Acetylation Via Sirt6

Bone marrow mesenchymal stem cell-derived exosomes have been found to reduce intervertebral disc degeneration by regulating a specific protein modification, which in turn helps to decrease inflammation.

Back pain is a widespread issue, often stemming from a condition called intervertebral disc degeneration, where the cushioning discs between our spinal bones wear down. Current treatments for this condition often have limitations, highlighting the need for new approaches.

Exciting new research points to the potential of tiny sacs, known as exosomes, released by special cells found in bone marrow. These “bone marrow mesenchymal stem cell-derived exosomes” act as messengers, carrying beneficial molecules to damaged areas.

This study reveals that these exosomes can significantly help in treating disc degeneration. They achieve this by influencing a key pathway that controls inflammation. Specifically, they promote the activity of a protein called SIRT6, which then removes a chemical tag from another protein, HMGB1. This action helps to calm down a major inflammatory process in the disc.

The findings show that these exosomes effectively reduce inflammation, prevent the death of important disc cells, and slow down the overall progression of disc degeneration. This discovery offers a promising new strategy for developing therapies to combat intervertebral disc degeneration and alleviate chronic back pain.

---

Source: link to paper